Watchlist

Watchlist
Alimera Sciences, Inc. (ALIM)
Alimera Sciences, Inc. (ALIM)
Alimera Sciences to Report Second Quarter 2018 Results July 30, 2018
ATLANTA , July 18, 2018 /PRNewswire/ --Alimera Sciences (NASDAQ: ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it will release its financial results for the second quarter ended June 30, 2018 , after the cl…
Alimera Sciences, Inc. (ALIM)